TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35467904

Group type: EXPERIMENTAL
Intervention: home‐MCT
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: usual CR plus home‐MCT
Number of subjects: 108

Group type: COMPARATOR
Intervention: telephone support calls
Number of subjects: 108
Study: 33940043

Group type: EXPERIMENTAL
Intervention: 1L-PEG+ASC
Number of subjects: 388
Study: 35337389

Group type: EXPERIMENTAL
Intervention: Lifestyle advice with or without metformin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 60
Study: 36153530

Group type: EXPERIMENTAL
Intervention: Target MAP of 80-85 mmHg (high-target)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Target MAP of 65-70 mmHg (control)
Number of subjects: 0
Study: 33766510

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study: 32387007

Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam
Number of subjects: 150

Group type: COMPARATOR
Intervention: Buccal midazolam
Number of subjects: 150
Study: 34618478

Group type: EXPERIMENTAL
Intervention: SOLAR group program (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control group (n = 15)
Number of subjects: 30
Study: 33789580

Group type: EXPERIMENTAL
Intervention: Quetiapine 12.5 mg once daily at bedtime for a maximum of 7 days
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo once daily at bedtime for a maximum of 7 days
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 33186500

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 33354559

Group type: EXPERIMENTAL
Intervention: Selective modified Sugiura procedure (sMSP group, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Modified Sugiura procedure (MSP group, n=30)
Number of subjects: 60
Study: 36133576

Group type: EXPERIMENTAL
Intervention: Task-based LSVT-BIG intervention (30 minutes of conventional occupational therapy and 40 minutes of task-based LSVT-BIG program, once a day, 5 times a week for 4 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Task-based LSVT-BIG intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (30 minutes of conventional occupational therapy and 40 minutes of relaxation and stretching, once a day, 5 times a week for 4 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study: 34593374

Group type: EXPERIMENTAL
Intervention: Virtual care with RAM technology (n=451)
Number of subjects: 905

Group type: COMPARATOR
Intervention: Standard care (n=454)
Number of subjects: 905
Study: 32999157

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Published case reports
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spontaneous reports
Number of subjects: 0
Study: 616787617

Group type: EXPERIMENTAL
Intervention: Training with the Key-Box (10-day training, 10 different exercises)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nontraining control group (no training)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Training with the Key-Box
Number of subjects: 16
Study: 35198517

Group type: EXPERIMENTAL
Intervention: Standardized information and breathing advice only (IBA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IBA plus inspiratory muscle training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IBA plus speech therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IBA plus inspiratory muscle training and speech therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (surgical)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimally invasive laser supraglottoplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 0
Study: 32634673

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone agonists (GnRHa)
Number of subjects: 55
Study: 36280988

Group type: EXPERIMENTAL
Intervention: Manual lumbar decompression, lumbar mobilisation, hot packs, TENS, and exercise therapy (Group A - acute)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lumbar mobilisation, hot packs, and exercise therapy (Group C - control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lumbar mobilisation, hot packs, and exercise therapy (Group B - chronic)
Number of subjects: 30
Study: 34836345

Group type: EXPERIMENTAL
Intervention: Remotely delivered weight loss intervention (diet and physical activity)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 159
Study: 34677151

Group type: EXPERIMENTAL
Intervention: Zufa syrup (7.5 mL every 4 hours for 10 days)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo syrup (identical-looking, 7.5 mL every 4 hours for 10 days)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Zufa syrup
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 116
Study: 33243742

Group type: EXPERIMENTAL
Intervention: Weight management combined with uvulopalatopharyngoplasty (UPPP) and cognitive-behavioral-psychological intervention for family weight management
Number of subjects: 60

Group type: COMPARATOR
Intervention: Uvulopalatopharyngoplasty (UPPP) with conventional management
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Weight management combined with uvulopalatopharyngoplasty (UPPP)
Number of subjects: 60
Study: 37304656

Group type: EXPERIMENTAL
Intervention: 10 min sitting meditation
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 30 min sitting meditation
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 10 min movement meditation
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 30 min movement meditation
Number of subjects: 161

Group type: COMPARATOR
Intervention: Movement meditation (all doses)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Sitting meditation (all doses)
Number of subjects: 161
Study: 34174463

Group type: EXPERIMENTAL
Intervention: recombinant human antithrombin gamma (rhAT-gamma)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal, fetal, and neonatal outcomes will be assessed.
Number of subjects: 0
Study: 35393864

Group type: EXPERIMENTAL
Intervention: Intervention details not available
Number of subjects: 0
Study: 33571294

Group type: EXPERIMENTAL
Intervention: Mechanical cervical ripening with a silicone double balloon catheter
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Pharmacological cervical ripening by a Propess vaginal pessary (prostaglandin E2 slow-release system)
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Pharmacological cervical ripening by a Propess vaginal pessary
Number of subjects: 1220
Study: 33354206

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 49
Study: 35334969

Group type: EXPERIMENTAL
Intervention: Curcumin (1000 mg) with ONS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (placebo with ONS)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Curcumin and Control (both with ONS)
Number of subjects: 12
Study: 34686614

Group type: EXPERIMENTAL
Intervention: High-Intensity Inspiratory Muscle Strength Training (HI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Inspiratory Muscle Strength Training (MOD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 35386840

Group type: COMPARATOR
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Number of subjects: 50
Study: 35001559

Group type: EXPERIMENTAL
Intervention: Purified reconstituted bilayer matrix (PRBM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 40
Study: 32773446

Group type: EXPERIMENTAL
Intervention: 40U DaxibotulinumtoxinA (DAXI)
Number of subjects: 2691
Study: 32795877

Group type: EXPERIMENTAL
Intervention: BPA (Bisphenol A)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: PrPB (Propylparaben)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: EtPB (Ethylparaben)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Total PBs concentrations
Number of subjects: 191
Study: 34587510

Group type: EXPERIMENTAL
Intervention: Medtronic Evolut PRO/PRO+ self‐expanding device
Number of subjects: 700

Group type: COMPARATOR
Intervention: Edwards SAPIEN 3/3 Ultra balloon‐expandable device
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 700
Study: 34153529

Group type: EXPERIMENTAL
Intervention: GIP
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: GLP-2
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: GIP + GLP-2
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 9
Study: 36066265

Group type: EXPERIMENTAL
Intervention: Clear aligners
Number of subjects: 32

Group type: COMPARATOR
Intervention: 2 × 4 fixed appliances
Number of subjects: 32
Study: 32964381

Group type: EXPERIMENTAL
Intervention: Active iTBS (intensive cerebellar intermittent theta burst stimulation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham iTBS (placebo control)
Number of subjects: 36
Study: 33099502

Group type: EXPERIMENTAL
Intervention: IPFP preservation
Number of subjects: 360

Group type: COMPARATOR
Intervention: IPFP resection
Number of subjects: 360
Study: 32891170

Group type: EXPERIMENTAL
Intervention: (1,3)-β-d-glucan group
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study: 34932018

Group type: EXPERIMENTAL
Intervention: 177Lu-Dotatate
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Scoring model based on risk factors (CgA, creatinine, previous chemotherapy)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Scoring model cut-off value of 29.7
Number of subjects: 195
Study: 33207656

Group type: EXPERIMENTAL
Intervention: GentleWave multisonic System
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional instrumentation and irrigation (positive control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ultrasonic irrigation using the Piezon Master 700
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ultrasonic irrigation with the ENDOSONIC Blue
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sonic irrigation with the EDDY
Number of subjects: 66
Study: 35772868

Group type: EXPERIMENTAL
Intervention: Novel mental health care bundle co-designed with parents and youth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing care protocols
Number of subjects: 0
Study: 32488934

Group type: EXPERIMENTAL
Intervention: Pilates exercise program for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapeutic exercises
Number of subjects: 0
Study: 36123866

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33001236

Group type: EXPERIMENTAL
Intervention: 1.25 mg levosimendan
Number of subjects: 183
Study: 33524994

Group type: EXPERIMENTAL
Intervention: Endocuff Vision
Number of subjects: 1813

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 1813
Study: 34886124

Group type: EXPERIMENTAL
Intervention: Workshop group (attended four in-person workshops)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Home-based group (no workshops)
Number of subjects: 15
Study: 32115033

Group type: COMPARATOR
Intervention: Inorganic trace minerals at 1/3 commercial levels (ITM)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Protein trace minerals at 1/3 commercial levels (TRT)
Number of subjects: 405
Study: 35910832

Group type: EXPERIMENTAL
Intervention: PBMT‐sMF before WOD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PBMT‐sMF after WOD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PBMT‐sMF before and after WOD
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo before and after WOD
Number of subjects: 12
Study: 32794485

Group type: EXPERIMENTAL
Intervention: Chronic periodontitis management (not specified in detail)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Healthy controlled diet, cultural background, education, FBG, CAL
Number of subjects: 118
Study: 35041042

Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.30 mg per kg/day, intravenous, twice daily for 3 days)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 33635424

Group type: EXPERIMENTAL
Intervention: 2.0% Tea Tree Oil (TTO)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.5% triclosan
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2.0% chlorhexidine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Reference soap
Number of subjects: 15
Study: 33143731

Group type: EXPERIMENTAL
Intervention: TXYF granule
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Whole transcriptome profiling
Number of subjects: 120
Study: 34757600

Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL with fasting plasma glucose (FPG) targets ≤ 5.6 mmol/L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL with fasting plasma glucose (FPG) targets ≤ 6.1 mmol/L
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL with fasting plasma glucose (FPG) targets ≤ 7.0 mmol/L
Number of subjects: 0
Study: 33797477

Group type: EXPERIMENTAL
Intervention: Arch-support foot-orthoses (ASFO)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham flat noncontoured orthoses
Number of subjects: 50
Study: 32491233

Group type: EXPERIMENTAL
Intervention: Intrauterine tocodynamometry (IT)
Number of subjects: 1504

Group type: COMPARATOR
Intervention: External tocodynamometry (ET)
Number of subjects: 1504
Study: 35412730

Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Outpatient-based cardiac rehabilitation
Number of subjects: 73

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 73
Study: 33895208

Group type: EXPERIMENTAL
Intervention: Caregiver reports of putting soil in their mouths at the majority of surveillance visits
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Caregiver reports of putting visibly dirty objects in their mouths at the majority of visits
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Households with unimproved sanitation
Number of subjects: 224
Study: 35485815

Group type: EXPERIMENTAL
Intervention: Oxidised dextran (ANDROEXPERT SV1) suppositories, rectally once per day for 10 days, then every other day for 20 days.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (cocoa butter) suppositories, rectally in a similar regimen.
Number of subjects: 52
Study: 33045783

Group type: EXPERIMENTAL
Intervention: 3D digital simulated design
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2D digital smile design
Number of subjects: 30
Study: 35134930

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Waiting List Group (Control)
Number of subjects: 5
Study: 34188125

Group type: EXPERIMENTAL
Intervention: Hangboard group HW (Hang weight, +1.25 kg weight added each week)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hangboard group HE (Hang endurance, grips to hold for a determined time decreased every week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group C (normal climbing training)
Number of subjects: 30
Study: 32352341

Group type: EXPERIMENTAL
Intervention: TRT + RT
Number of subjects: 22

Group type: COMPARATOR
Intervention: TRT
Number of subjects: 22
Study: 33652980

Group type: EXPERIMENTAL
Intervention: Contact with family/relatives
Number of subjects: 1365

Group type: EXPERIMENTAL
Intervention: Contact with friends/neighbors
Number of subjects: 1365
Study: 616684312

Group type: EXPERIMENTAL
Intervention: Endovenous laser obliteration (laser group, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional surgical ligation (traditional group, n=20)
Number of subjects: 40
Study: 36123964

Group type: EXPERIMENTAL
Intervention: Codeine (60 mg/day for 2 weeks)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Levodropropizine (180 mg/day for 2 weeks)
Number of subjects: 88
Study: 35286750

Group type: EXPERIMENTAL
Intervention: RHG + RME (22 patients)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (C-G, 22 patients)
Number of subjects: 44
Study: 32602233

Group type: EXPERIMENTAL
Intervention: Recommended dairy (RDa; n = 24)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Low dairy (LDa; n = 22)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (Con; n = 8)
Number of subjects: 54
Study: 36189778

Group type: EXPERIMENTAL
Intervention: Behavioral strategies (e.g., prompting and rewards)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Unintended negative effects assessment
Number of subjects: 193
Study: 33485454

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: BPD and RYGB (compared to medical therapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BPD
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 60
Study: 32195954

Group type: EXPERIMENTAL
Intervention: Paraffin therapy (20 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no paraffin therapy)
Number of subjects: 20
Study: 36126995

Group type: EXPERIMENTAL
Intervention: Usual CF care plus a longitudinal palliative care intervention delivered by a palliative care specialist
Number of subjects: 264

Group type: COMPARATOR
Intervention: Usual CF care alone
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Usual CF care plus a longitudinal palliative care intervention
Number of subjects: 264
Study: 33319250

Group type: COMPARATOR
Intervention: ART children
Number of subjects: 57

Group type: COMPARATOR
Intervention: Culture media
Number of subjects: 57
Study: 33992897

Group type: EXPERIMENTAL
Intervention: Patient-controlled intravenous analgesia (PCA)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (EDA)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 43
Study: 32081656

Group type: EXPERIMENTAL
Intervention: Sleeping on an inflatable cushion elevating the upper body by 30º
Number of subjects: 134

Group type: COMPARATOR
Intervention: Sham pillow in a horizontal position (Control)
Number of subjects: 134
Study: 33477106

Group type: EXPERIMENTAL
Intervention: Passive cooldown
Number of subjects: 16

Group type: COMPARATOR
Intervention: Active cooldown
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cooldown duration of 15 minutes
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cooldown duration of 10 minutes
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cooldown duration of 5 minutes
Number of subjects: 16
Study: 35147680

Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (40mg/kg intravenous liposomal amphotericin B administered in 8 equal doses over 24 days)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination therapy (30mg/kg intravenous liposomal amphotericin B administered in 6 equal doses over 24 days + 1.4g oral miltefosine administered in two daily doses of 50mg over 14 days)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (excluding those with concurrent tuberculosis)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination therapy (excluding those with concurrent tuberculosis)
Number of subjects: 150
Study: 33382101

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) as an adjunct to scaling and root planing (ScRp)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Scaling and root planing (ScRp) only
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 12
Study: 32796259

Group type: EXPERIMENTAL
Intervention: Supervised exercise (n=86)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Telehealth exercise (n=95)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control group (n=83)
Number of subjects: 264
Study: 35986498

Group type: EXPERIMENTAL
Intervention: HEAVY‐IT
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: MODERATE‐IT
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Exercise training (both MODERATE‐IT and HEAVY‐IT)
Number of subjects: 27
Study: 33119948

Group type: EXPERIMENTAL
Intervention: 300 g day‐1 RS‐enriched potatoes (approximately two potatoes; 18 g RS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: CHO‐based control foods
Number of subjects: 19
Study: 33026166

Group type: EXPERIMENTAL
Intervention: BACPPI (20 mg of rabeprazole, 1000 mg of amoxicillin, 500 mg of clarithromycin, and 220 mg of bismuth potassium citrate) for 10 days
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: BACPPI (20 mg of rabeprazole, 1000 mg of amoxicillin, 500 mg of clarithromycin, and 220 mg of bismuth potassium citrate) for 14 days
Number of subjects: 240

Group type: COMPARATOR
Intervention: BACPPI-10 group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study: 36016905

Group type: EXPERIMENTAL
Intervention: Humanistic nursing practice guidelines for stroke patients
Number of subjects: 25
Study: 32152175

Group type: EXPERIMENTAL
Intervention: Plasma adsorption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34881843

Group type: EXPERIMENTAL
Intervention: CGF+CAF
Number of subjects: 18

Group type: COMPARATOR
Intervention: PRF+CAF
Number of subjects: 18
Study: 32304333

Group type: EXPERIMENTAL
Intervention: Microbial richness and specific phylogenetic classes
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Abundance of genera in Gammaproteobacteria (Haemophilus, Klebsiella, Buttiauxella, Raoultella)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Building age
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Weight of vacuum dust
Number of subjects: 357
Study: 33503390

Group type: EXPERIMENTAL
Intervention: Keeogo™ exoskeleton
Number of subjects: 29